We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-0.44%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.41B
AUM Growth
-$143M
Cap. Flow
-$108M
Cap. Flow %
-7.65%
Top 10 Hldgs %
40.58%
Holding
226
New
9
Increased
48
Reduced
78
Closed
10

Top Buys

Rank Stock Value
1
SO icon
Southern Company
SO
+$3.36M
2
PCOR icon
Procore
PCOR
+$1.51M
3
TJX icon
TJX Companies
TJX
+$1.37M
4
HD icon
Home Depot
HD
+$1.2M
5
HPQ icon
HP
HPQ
+$1.16M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$45.4M
2
WMT icon
Walmart Inc
WMT
+$20.5M
3
WST icon
West Pharmaceutical
WST
+$9.83M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.45M
5
TSLA icon
Tesla
TSLA
+$4.67M

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Financials 17.13%
3 Consumer Staples 16.22%
4 Healthcare 10.07%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFX icon
126
Equifax
EFX
$20.8B
$1.04M 0.07%
4,250
– –
AZN icon
127
AstraZeneca
AZN
$250B
$957K 0.07%
6,513
– –
FSLR icon
128
First Solar
FSLR
$25.4B
$948K 0.07%
7,500
– –
SCHW
129
Charles Schwab
SCHW
$188B
$932K 0.07%
11,900
+400
+3% +$31.4K
EW icon
130
Edwards Lifesciences
EW
$51.3B
$913K 0.06%
12,600
– –
UBS icon
131
UBS Group
UBS
$176B
$888K 0.06%
29,000
– –
PNC icon
132
PNC Financial Services
PNC
$102B
$855K 0.06%
4,862
– –
VZ icon
133
Verizon
VZ
$193B
$854K 0.06%
18,834
-216
-1% -$8.99K
GILD icon
134
Gilead Sciences
GILD
$164B
$848K 0.06%
7,567
-7,574
-50% -$782K
SYY icon
135
Sysco
SYY
$40.3B
$825K 0.06%
11,000
– –
A icon
136
Agilent Technologies
A
$39.9B
$819K 0.06%
7,000
– –
T icon
137
AT&T
T
$158B
$816K 0.06%
28,855
– –
BX icon
138
Blackstone
BX
$109B
$811K 0.06%
5,800
-4,300
-43% -$698K
NUE icon
139
Nucor
NUE
$62.6B
$766K 0.05%
6,369
– –
LNC icon
140
Lincoln National
LNC
$8.98B
$747K 0.05%
20,800
– –
KMB icon
141
Kimberly-Clark
KMB
$37.4B
$725K 0.05%
5,100
– –
FITB
142
Fifth Third Bancorp
FITB
$52.2B
$721K 0.05%
18,400
– –
TT icon
143
Trane Technologies
TT
$106B
$708K 0.05%
2,100
– –
GD icon
144
General Dynamics
GD
$104B
$703K 0.05%
2,579
– –
GPC icon
145
Genuine Parts
GPC
$18.1B
$703K 0.05%
5,900
– –
DASH icon
146
DoorDash
DASH
$90.3B
$699K 0.05%
3,825
-3,175
-45% -$597K
BLK icon
147
Blackrock
BLK
$176B
$678K 0.05%
716
-200
-22% -$196K
NKE icon
148
Nike
NKE
$63B
$668K 0.05%
10,520
+500
+5% +$36.8K
SHW icon
149
Sherwin-Williams
SHW
$89.7B
$663K 0.05%
1,900
– –
BAX icon
150
Baxter International
BAX
$14.1B
$640K 0.05%
18,700
– –
4 5
6
7 8

Similar funds

MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return

Cullinan Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Cullinan Associates held 226 positions worth $1.41B, down 9.2% from $1.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cullinan Associates withdrew a net $108M in Q1 2025, closing 10 positions and reducing 78 holdings. Its most notable exit was West Pharmaceutical, an estimated $9.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Cullinan Associates opened a new position in Procore worth $1.32M.

  • Cullinan Associates's largest Q1 2025 buy was Procore: 20,000 shares worth $1.32M.
  • Cullinan Associates added most to Southern Company in Q1 2025, an estimated $3.36M increase.
  • Cullinan Associates's biggest Q1 2025 reduction was Apple, cutting an estimated $45.4M.
  • Cullinan Associates fully exited West Pharmaceutical in Q1 2025, selling an estimated $9.83M.
  • Cullinan Associates's ten largest holdings make up 41% of its $1.41B portfolio in Q1 2025.
  • Cullinan Associates opened 9 new positions and closed 10 in Q1 2025.
  • Cullinan Associates's portfolio value fell 9.2% quarter-over-quarter to $1.41B.

Based on Cullinan Associates's 13F filing for Q1 2025, filed 22 Apr 2025.